Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 9Unknown 6Recruiting 5Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Gynecologic Surgical Procedures 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Enhanced Recovery After Surgery × Clear all
NCT04505111 2022-04-11

Prehabilitation Plus ERAS vs ERAS in Gynecological Surgery

Instituto Brasileiro de Controle do Cancer

Phase NA Withdrawn

Gynecologic Surgical Procedures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡